CC0 PUBLIC RECORD GRAPH Every score & timeline item links directly to its underlying U.S. FDA record (openFDA, ORA FOIA Reading Room, DECRS & OASIS).
Scoring Formula v2.0 & Legal Guardrails REST API v1
FG
GMPGraphv2.0
Global FDA Facility Graph & Co-Packer Intelligence
21 CFR Encyclopedia → 21 CFR 111.260(e)
21 CFR 111.260(e) Dietary Supplements 239 Annual Form 483 Citations

21 CFR 111.260(e) — Incomplete Batch Production Record (BPR) — missing component weights and lot numbers

Plain-English Risk Theme: Master Manufacturing & Batch Production Records (MMR/BPR) · Official eCFR Text ↗
🛡️ Test Your SOP Against 21 CFR 111.260(e) →
Official FDA Inspectional Observation Template
"Your batch production records failed to include complete information relating to the production and control of each batch, including the identity and weight or measure of each component used and the unique lot number assigned."
Plain-English Brand & QA Translation
Missing Master Manufacturing Records (MMRs) or incomplete Batch Production Records (BPRs) lacking exact component weights, lot numbers, yield reconciliation, or second-person verification.
🚨 Why 15-Day Form 483 Responses Fail on 21 CFR 111.260(e):
FDA routinely rejects 15-day Form 483 responses for 21 CFR 111.260(e) when a facility merely states 'we revised our SOP and retrained personnel' without attaching: (1) the signed, effective-dated SOP, (2) photographic or batch-log proof of implementation, and (3) a retrospective impact assessment of all commercial lots manufactured over the prior 24 months within expiry.
✅ Standard 15-Day CAPA Remediation Blueprint:
  1. Immediate Containment (Days 1–3): Place affected raw materials or in-process lots on QA Hold and open formal CAPA under 21 CFR 111.260(e).
  2. Systemic Root-Cause & SOP Overhaul (Days 4–10): Ensure every product SKU has an approved MMR matching the exact label claim and every batch record captures raw material lot traceability, in-process weight/pH checks, and QA release signatures.
  3. Retrospective Lot Review & Effectiveness Check (Days 11–15): Test retention samples of distributed lots and schedule a 30/60/90-day QA audit to prove sustained compliance.

Copy-Paste Compliant SOP Clause Template (21 CFR 111.260(e))

FREE AUDIT-READY BOILERPLATE 
STANDARD OPERATING PROCEDURE — COMPLIANCE CLAUSE 21 CFR 111.260(e)
1. PURPOSE: Establish mandatory cGMP controls satisfying 21 CFR 111.260(e) (Incomplete Batch Production Record (BPR) — missing component weights and lot numbers).
2. REQUIREMENT: Ensure every product SKU has an approved MMR matching the exact label claim and every batch record captures raw material lot traceability, in-process weight/pH checks, and QA release signatures.
3. QA VERIFICATION & SIGN-OFF: Dual independent verification by Production and Quality Assurance Unit (QAU) is required prior to batch release. Any deviation or Out-of-Specification (OOS) result triggers a formal CAPA investigation within 24 hours.

FDA Investigators Who Frequently Cite 21 CFR 111.260(e)

Elena R. Rostova (Pacific Southwest Division (Los Angeles District)) →

Published Form 483s Citing 21 CFR 111.260(e)

Indexed in FDA ORA Inspectional Observations dataset.